Almost every patient who arrives at AgeRejuvenation with chronic fatigue, brain fog, joint pain, autoimmune symptoms, mood disturbances, or skin issues shares one underlying pattern, and most of them have never been told about it. Their gut barrier is compromised. KLOW combines two peptides, KPV and BPC-157, with the goal of calming the inflammatory immune signaling and supporting repair of the intestinal lining, so the body can settle the low-grade inflammation that has often been running for years.
At AgeRejuvenation, the KLOW peptide stack is used as a gut-restoration protocol rather than a quick fix, and it is always prescribed and supervised after we understand your symptoms and testing. This guide explains what the KLOW stack is, how its two peptides work, what it may support, who tends to be a candidate, how it is administered, the safety considerations, what to expect, and how it compares to single-peptide and over-the-counter alternatives.
What Is the KLOW Peptide Stack?
Answer: KLOW is a two-peptide combination of KPV and BPC-157 used to address both sides of gut dysfunction at once: the inflammatory immune signaling on one side and the integrity of the intestinal barrier on the other.
The idea behind pairing the two is that they work on different problems. KPV is a tripeptide related to alpha-melanocyte-stimulating hormone and is studied for its anti-inflammatory signaling. BPC-157 is derived from a protective compound found in gastric juice and is studied in the context of tissue repair. Combining them aims to calm inflammatory activity while supporting repair of the lining, which is why the stack is described as dual-action rather than a single mechanism.
How Do KPV and BPC-157 Work in the KLOW Stack?
Answer: KPV is studied for calming inflammatory immune signaling, while BPC-157 is studied for supporting tissue repair; together the KLOW stack aims to reduce inflammation and help restore the gut barrier rather than relying on either effect alone.
When the barrier between the gut and the bloodstream weakens, bacterial fragments and other compounds can cross where they do not belong, and the immune system responds. Researchers describe how compounds from the gut reach the bloodstream and fuel systemic disease when that control is lost. KPV is intended to modulate inflammatory signaling without broadly suppressing the immune system, while BPC-157 is intended to support the structural lining the immune signaling is reacting to. The two are meant to be complementary.
What Does the Gut Barrier Have to Do With the Rest of the Body?
Answer: The gut hosts a large share of the body's immune tissue, so when the intestinal barrier is compromised the resulting inflammation can show up far from the digestive tract, in joints, skin, energy, and cognition.
This is the part patients are most often surprised by. Cleveland Clinic explains how the gut barrier interacts with the immune system and why a weakened barrier can let bacterial toxins escape into circulation. That circulating inflammatory load is what connects a digestive problem to symptoms most people would never associate with the gut, which is why repairing the barrier sometimes improves things that seem unrelated.
What Is "Leaky Gut," and Is KLOW a Treatment for It?
Answer: "Leaky gut" is a common term for increased intestinal permeability; KLOW is used to support the barrier and reduce inflammation, but it is part of a supervised plan, not a stand-alone cure.
It helps to be precise here. The increased permeability described as what increased intestinal permeability means is a real phenomenon seen in certain conditions, even though "leaky gut syndrome" is not a formal stand-alone diagnosis. We use KLOW to target the barrier and the inflammatory signaling, but we do not present it as a guaranteed cure, and we evaluate each person before recommending it.
What May the KLOW Stack Support?
Answer: KLOW may support gut barrier integrity, lower inflammatory signaling, and, downstream, may ease symptoms tied to chronic inflammation such as bloating, fatigue, brain fog, joint discomfort, and certain inflammatory skin patterns.
These are framed as may-support outcomes, not promises. Because so much immune activity is rooted in the gut, the same process that influences digestion can influence energy and clarity, which is why chronic fatigue sometimes lifts as the inflammatory load settles. The size and timing of any benefit are individual, and we track them against your symptoms and testing rather than assuming a fixed result.
Who Is a Candidate for KLOW Peptide Therapy?
Answer: The best candidates are patients whose symptoms trace back to gut inflammation and chronic inflammatory dysregulation, including digestive complaints, autoimmune-flavored inflammation, persistent fatigue, brain fog, and stubborn inflammatory skin issues.
Candidacy is decided clinically, not by symptom list alone. We review your history, rule out other drivers, and often order stool analysis, food-sensitivity panels, and inflammatory markers before recommending the protocol. Patients with autoimmune conditions are evaluated carefully, because the goal is to modulate inflammation thoughtfully rather than broadly suppress immune function.
How Is KLOW Administered and Supervised?
Answer: KLOW is a prescribed, physician-supervised peptide protocol delivered as part of a broader gut-restoration plan, with the specific regimen set during your evaluation rather than by any fixed schedule.
We do not publish a universal dose, because the right protocol depends on your testing, symptoms, and history, and dosing guidance belongs in your individual visit, not a web page. What is consistent is the structure: evaluation first, supervised use under Dr. Dawn Ericsson and the clinical team, and follow-up to see how your body responds and whether adjustments are warranted.
Is KLOW Safe? Side Effects and Considerations
Answer: KLOW is intended to modulate rather than broadly suppress immune function, but like any therapy it carries considerations, so it is used under medical supervision with appropriate testing rather than self-directed.
The clinical reasoning for pairing these peptides is to influence the inflammatory and immune response described in references on how inflammation and the immune response unfold in the body without the trade-offs people associate with long-term corticosteroids or NSAIDs. That said, peptide therapies are an area of ongoing study, individual responses vary, and we screen for conditions and medications that change the picture. Supervision is the safeguard, which is why we monitor rather than prescribe once and walk away.
What Should I Expect on a KLOW Protocol?
Answer: Patients typically begin a supervised course alongside lifestyle and nutritional support, with digestive symptoms often the first to shift and systemic changes, such as energy or skin, sometimes following as inflammation settles.
Timelines are individual and we avoid promising specific numbers. Many people notice digestive changes earlier than systemic ones, and because the systemic effects are downstream of the inflammatory load, they can take longer and arrive quietly. We check in, review how you feel against your testing, and decide whether to continue, adjust, or layer in other parts of the plan.
KLOW vs. Single Peptides and Probiotics
Answer: KLOW differs from single-peptide and probiotic approaches because it targets two layers of gut dysfunction, inflammatory signaling and barrier repair, rather than one, and it is a repair-oriented protocol rather than a bacteria-additive supplement.
| Approach | What it targets | Typical role |
|---|---|---|
| KLOW stack (KPV + BPC-157) | Inflammatory signaling and barrier repair together | Dual-action, physician-supervised gut-restoration protocol |
| KPV alone | Inflammatory signaling | Anti-inflammatory focus without the repair-oriented partner |
| BPC-157 alone | Tissue and barrier repair | Repair focus without the dedicated anti-inflammatory partner |
| Probiotics | Microbiome composition | Adds bacteria; does not directly rebuild the barrier |
The point of the stack is that the two peptides address different problems, so combining them is meant to be more complete than either one on its own, and it is distinct from a probiotic, which adds organisms rather than restoring the lining. The right approach for you is decided in your evaluation.
Why Choose AgeRejuvenation for KLOW?
Answer: Gut health rarely heals in isolation, so the most effective KLOW protocols are embedded in a broader plan that addresses nutrition, stress and nervous-system health, and the hormonal factors that influence the gut barrier.
Care is led by Dr. Dawn Ericsson and a clinical team experienced in complex, multi-system inflammatory conditions, often in patients who had been passed from specialist to specialist without resolution. Comprehensive stool analysis, food-sensitivity panels, and inflammatory markers are frequently ordered alongside the protocol. KLOW sits within our broader peptide therapy program and is available across our Florida locations, supervised from your first evaluation through follow-up.
Explore more in our wellness center services .
